Allogeneic CD19-CAR T cells (second generation)

CD19-CAR T cells · Bambino Gesù Hospital and Research Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic CD19-CAR T cells (second generation), covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL [Phase 1]